<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>132(8)</volume><submitter>Tang F</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>The heterogeneity of tumors significantly impacts on colorectal cancer (CRC) progression. However, the influence of this heterogeneity on the spatial architecture of CRC remains largely unknown.&lt;h4>Methods&lt;/h4>Spatial transcriptomic (ST) analysis of AOM/DSS-induced colorectal cancer (CRC), integrated with single-cell RNA sequencing, generated a comprehensive spatial atlas of CRC. Pseudotime trajectory, stemness evaluation, and cell-cell communication analyses explored how CD44&lt;sup>+&lt;/sup> tumor cells at the leading edge remodel the tumor microenvironment (TME). In vitro experiments and immunofluorescence staining of clinical samples validated pleiotrophin (PTN) signaling in promoting cancer-associated fibroblasts (CAFs) phenotypic transition and CRC progression.&lt;h4>Results&lt;/h4>Our findings revealed a distinctive layered ring-like structure within CRC tissues, where CD44&lt;sup>+&lt;/sup> tumor cells exhibiting high stemness were positioned at the tumor's leading edge. Inflammatory CAFs (iCAFs)-like, myofibroblastic CAFs (myCAFs)-like cells and pro-tumorigenic neutrophils primarily located at the tumor edge, in proximity to CD44&lt;sup>+&lt;/sup> tumor cells. CD44&lt;sup>+&lt;/sup> tumor cells then triggered the phenotypic transition of CAFs into iCAF-like and myCAF-like cells through PTN signaling.&lt;h4>Conclusions&lt;/h4>Our results provide distinctive insights into how tumor heterogeneity reshapes the TME at the leading edge of tumor, thereby promoting CRC progression.</pubmed_abstract><journal>British journal of cancer</journal><pagination>703-715</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11997037</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>CD44&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; cells enhance pro-tumor stroma in the spatial landscape of colorectal cancer leading edge.</pubmed_title><pmcid>PMC11997037</pmcid><pubmed_authors>Sun L</pubmed_authors><pubmed_authors>Shen J</pubmed_authors><pubmed_authors>Zhu Y</pubmed_authors><pubmed_authors>Yuan B</pubmed_authors><pubmed_authors>He X</pubmed_authors><pubmed_authors>Tian Y</pubmed_authors><pubmed_authors>Weng L</pubmed_authors><pubmed_authors>Tang F</pubmed_authors></additional><is_claimable>false</is_claimable><name>CD44&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; cells enhance pro-tumor stroma in the spatial landscape of colorectal cancer leading edge.</name><description>&lt;h4>Background&lt;/h4>The heterogeneity of tumors significantly impacts on colorectal cancer (CRC) progression. However, the influence of this heterogeneity on the spatial architecture of CRC remains largely unknown.&lt;h4>Methods&lt;/h4>Spatial transcriptomic (ST) analysis of AOM/DSS-induced colorectal cancer (CRC), integrated with single-cell RNA sequencing, generated a comprehensive spatial atlas of CRC. Pseudotime trajectory, stemness evaluation, and cell-cell communication analyses explored how CD44&lt;sup>+&lt;/sup> tumor cells at the leading edge remodel the tumor microenvironment (TME). In vitro experiments and immunofluorescence staining of clinical samples validated pleiotrophin (PTN) signaling in promoting cancer-associated fibroblasts (CAFs) phenotypic transition and CRC progression.&lt;h4>Results&lt;/h4>Our findings revealed a distinctive layered ring-like structure within CRC tissues, where CD44&lt;sup>+&lt;/sup> tumor cells exhibiting high stemness were positioned at the tumor's leading edge. Inflammatory CAFs (iCAFs)-like, myofibroblastic CAFs (myCAFs)-like cells and pro-tumorigenic neutrophils primarily located at the tumor edge, in proximity to CD44&lt;sup>+&lt;/sup> tumor cells. CD44&lt;sup>+&lt;/sup> tumor cells then triggered the phenotypic transition of CAFs into iCAF-like and myCAF-like cells through PTN signaling.&lt;h4>Conclusions&lt;/h4>Our results provide distinctive insights into how tumor heterogeneity reshapes the TME at the leading edge of tumor, thereby promoting CRC progression.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 May</publication><modification>2026-06-03T01:17:28.313Z</modification><creation>2025-07-03T03:06:43.381Z</creation></dates><accession>S-EPMC11997037</accession><cross_references><pubmed>40069574</pubmed><doi>10.1038/s41416-025-02968-9</doi></cross_references></HashMap>